SCHEMBL4619445

SCHEMBL4619445

CC(=O)C(N)CC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14227024 0.81 GRIK1 (0.41)
SCHEMBL14227026 0.81 GRIK1 (0.41)
SCHEMBL24296090 0.81 GRIK1 (0.41)
SCHEMBL13979544 0.77 GRIK1 (0.53)
SCHEMBL16204243 0.77
SCHEMBL13176684 0.77
SCHEMBL26537599 0.77
SCHEMBL4472181 0.76
SCHEMBL4291341 0.76
SCHEMBL468961 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230358732-A1 METHODS AND COMPOUNDS FOR DETECTION AND BINDING OF ALDEHYDES UNIVERSITY OF OTTAWA (CA) 2023-11-09 US disclosed
US-20100144655-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2010-06-10 US disclosed
EP-1893767-A1 PROCESS FOR PRODUCING ATORVASTATIN, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND INTERMEDIATES THEREOF Pfizer, Inc. (US) 2008-03-05 EP disclosed
WO-2006134482-A1 PROCESS FOR PRODUCING ATORVASTATIN, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND INTERMEDIATES THEREOF PFIZER INC. (US) 2006-12-21 WO disclosed